---
title: "康宁杰瑞制药-B 的 KN035 已被中国监管机构接受审查"
description: "阿尔法玛肿瘤学的 KN035 已被接受进行中国监管审查"
type: "news"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/news/272214027.md"
published_at: "2026-01-12T03:55:44.000Z"
---

# 康宁杰瑞制药-B 的 KN035 已被中国监管机构接受审查

> 阿尔法玛肿瘤学的 KN035 已被接受进行中国监管审查

### Related Stocks

- [09966.HK - 康宁杰瑞制药-B](https://longbridge.com/zh-CN/quote/09966.HK.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| Alphamab Oncology Files HKEX Disclosure on 500,000 Share Repurchase at HKD 4.83 Million | Alphamab Oncology has disclosed a share repurchase of 500,000 shares for a total of HKD 4,833,510, as reported to the Ho | [Link](https://longbridge.com/zh-CN/news/271193146.md) |
| Alphamab Oncology Wins CDE Approval for Phase II JSKN033 Cervical Cancer Trial | Alphamab Oncology has received approval from the Center for Drug Evaluation (CDE) for its phase II clinical trial of JSK | [Link](https://longbridge.com/zh-CN/news/270949036.md) |
| Gates Foundation says it did not make any payments to Epstein | The Gates Foundation clarified that it did not make any payments to Jeffrey Epstein or employ him. This statement follow | [Link](https://longbridge.com/zh-CN/news/275653390.md) |
| ZAWYA-PRESSR: Emirates Health Platform showcases national efforts to advance health policies and legislation through digital solutions | The Emirates Health platform showcased key projects at the World Health Expo 2026 in Dubai, emphasizing the collaboratio | [Link](https://longbridge.com/zh-CN/news/275625609.md) |
| ‘XRP is the North Star for Ripple’: Garlinghouse keeps door open for more M&A in second half of 2026 | Ripple CEO Brad Garlinghouse indicated that while significant acquisitions are unlikely in the near term, he remains ope | [Link](https://longbridge.com/zh-CN/news/275646537.md) |

---

> **免责声明**：本文内容仅供参考，不构成任何投资建议。